[en] In mammals, Ins(1,4,5)P3, the well known calcium mobilization messenger, is phosphorylated in the cytosol at the 3-position of the inositol ring to yield Ins(1,3,4,5)P4 by Ins(1,4,5)P3 3-kinases A, B and C isoforms as well as by inositol polyphosphate multikinase (Ipmk). Studies in gene-deficient mice have revealed that these enzymes and Ins(1,3,4,5)P4, their reaction product, play essential role in multiple physiological processes, ranging from synaptic plasticity, hematopoietic cell survival, development and function, to mRNA export, transcriptional regulation and chromatin remodelling. Rather than to provide an unique and “universal” mechanism of Ins(1,3,4,5)P4 action, these studies in genetically-modified mice point for a role of this inositide in the control of calcium mobilization, of the subcellular localisation of PH domain-containing target proteins, and of higher inositol phosphate production. Mice deficient for the B isoform of inositol 1,4,5-trisphosphate 3-kinase (Itpkb) develop profound alterations in T and B cells as well as in neutrophils and mast cells. Our recent studies indicate that the 3-kinase Itpkb and Ins(1,3,4,5)P4 are important for the survival of naïve mature B cells and the control of proapoptotic Bim protein expression, rather than for the control of B cell transition from one developmental stage to another. They also suggest that Itpkb is an important component in the control of B cell anergy.
Schurmans, Stéphane ; Université de Liège - ULiège > Département de sciences fonctionnelles > Biochimie métabolique vétérinaire
Pouillon, V.; Université Libre de Bruxelles - ULB > Institut de Recherches Interdisciplinaires en Biologie Humaine et Moléculaire (IRIBHM), Institut de Biologie et de Médecine
Marechal, Y.; Université Libre de Bruxelles - ULB > Institut de Recherches Interdisciplinaires en Biologie Humaine et Moléculaire (IRIBHM), Institut de Biologie et de Médecine
Language :
English
Title :
Regulation of B cell survival, development and function by inositol 1,4,5-trisphosphate 3-kinase B (Itpkb)
Balla T. Pharmacology of phosphoinositides, regulators of multiple cellular functions. Curr Pharm Des 2001, 7:475-507.
Burgner D., Davila S., Breunis W.B., Ng S.B., Li Y., Bonnard C., et al. International Kawasaki Disease Genetics Consortium. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet 2009, 5. e1000319.
Cockcroft S., De Matteis M.A. Inositol lipids as spatial regulators of membrane traffic. J Membr Biol 2001, 180:187-194.
Cullen P.J., Irvine R.F., Dawson AP Synergistic control of Ca2+ mobilization in permeabilized mouse L1210 lymphoma cells by inositol 2,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate. Biochem J 1990, 271:549-553.
Cullen P.J. Bridging the GAP in inositol 1,3,4,5-tetrakisphosphate signalling. Biochim Biophys Acta 1998, 1436:35-47.
Dewaste V., Roymans D., Moreau C., Erneux C. Cloning and expression of a full-length cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase B. Biochem Biophys Res Commun 2002, 291:400-405.
Dewaste V., Moreau C., De Smedt F., Bex F., De Smedt H., Wuytack F., et al. The three isoenzymes of human inositol-1,4,5-trisphosphate 3-kinase show specific intracellular localization but comparable Ca2+ responses on transfection in COS-7 cells. Biochem J 2003, 374:41-49.
Foyouzi-Youssefi R., Arnaudeau S., Borner C., Kelley W.L., Tschopp J., Lew D.P., et al. Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. Proc Natl Acad Sci U S A 2000, 97:5723-5728.
Hata A., Onouchi Y. Susceptibility genes for Kawasaki disease: toward implementation of personalized medicine. J Hum Genet 2009, 54:67-73.
Hermosura M.C., Takeuchi H., Fleig A., Riley A.M., Potter B.V., Hirata M., et al. InsP4 facilitates store-operated calcium influx by inhibition of InsP3 5-phosphatase. Nature 2000, 408:735-740.
Huang Y.H., Grasis J.A., Miller A.T., Xu R., Soonthornvacharin S., Andreotti A.H., et al. Positive regulation of Itk PH domain function by soluble IP4. Science 2007, 316:886-889.
Irvine R.F. Inositol phosphates: does IP(4) run a protection racket?. Curr Biol 2001, 11:R172-R174.
Irvine R.F., Schell M.J. Back in the water: the return of the inositol phosphates. Nat Rev Mol Cell Biol 2001, 2:327-338.
Irvine R.F. 20 years of Ins(1,4,5)P3, and 40 years before. Nat Rev Mol Cell Biol 2003, 4:586-590.
Jia Y., Subramanian K.K., Erneux C., Pouillon V., Hattori H., Jo H., et al. Luo HR. Inositol 1,3,4,5-tetrakisphosphate negatively regulates phosphatidylinositol-3,4,5- trisphosphate signaling in neutrophils. Immunity 2007, 27:453-467.
Jia Y., Loison F., Hattori H., Li Y., Erneux C., Park S.Y., et al. Luo HR. Inositol trisphosphate 3-kinase B (InsP3KB) as a physiological modulator of myelopoiesis. Proc Natl Acad Sci U S A 2008, 105:4739-4744.
Jia Y., Schurmans S., Luo H.R. Regulation of innate immunity by inositol 1,3,4,5-tetrakisphosphate. Cell Cycle 2008, 7:2803-2808.
Johnson H.W., Schell M.J. Neuronal IP3 3-kinase is an F-actin bundling protein: role in dendritic targeting and regulation of spine morphology. Mol Biol Cell 2009, 20:5166-5180.
Jun K., Choi G., Yang S.G., Choi K.Y., Kim H., Chan G.C., et al. Shin HS. Enhanced hippocampal CA1 LTP but normal spatial learning in inositol 1,4,5-trisphosphate 3-kinase(A)-deficient mice. Learn Mem 1998, 5:317-330.
Leyman A., Pouillon V., Bostan A., Schurmans S., Erneux C., Pesesse X. The absence of expression of the three isoenzymes of the inositol 1,4,5-trisphosphate 3-kinase does not prevent the formation of inositol pentakisphosphate and hexakisphosphate in mouse embryonic fibroblasts. Cell Signal 2007, 19:1497-1504.
Mailleux P., Takazawa K., Erneux C. Vanderhaeghen JJ. Inositol 1,4,5-trisphosphate 3-kinase distribution in the rat brain. High levels in the hippocampal CA1 pyramidal and cerebellar Purkinje cells suggest its involvement in some memory processes. Brain Res 1991, 539:203-210.
Maréchal Y., Pesesse X., Jia Y., Pouillon V., Pérez-Morga D., Daniel J., et al. Schurmans S. Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Proc Natl Acad Sci U S A 2007, 104:13978-13983.
Maréchal Y, Quéant S, Polizzi S, Pouillon V, Schurmans S. Inositol 1,4,5-trisphosphate 3-kinase B controls survival and prevents anergy in B cells. Immunobiology 2010; in press.
Michell R.H. First came the link between phosphoinositides and Ca2+ signalling, and then a deluge of other phosphoinositide functions. Cell Calcium 2009, 45:521-526.
Miller A.T., Sandberg M., Huang Y.H., Young M., Sutton S., Sauer K., et al. Production of Ins(1,3,4,5)P4 mediated by the kinase Itpkb inhibits store-operated calcium channels and regulates B. Cell Selection activation. Nat Immunol 2007, 8:514-521.
Miller A.T., Beisner D.R., Liu D., Cooke M.P. Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction. J Immunol 2009, 182:4696-4704.
Nalaskowski M.M., Bertsch U., Fanick W., Stockebrand M.C., Schmale H., Mayr G.W. Rat inositol 1,4,5-trisphosphate 3-kinase C is enzymatically specialized for basal cellular inositol trisphosphate phosphorylation and shuttles actively between nucleus and cytoplasm. J Biol Chem 2003, 278:19765-19776.
Nalaskowski M.M., Windhorst S., Stockebrand M.C., Mayr G.W. Subcellular localisation of human inositol 1,4,5-trisphosphate 3-kinase C: species-specific use of alternative export sites for nucleo-cytoplasmic shuttling indicates divergent roles of the catalytic and N-terminal domains. Biol Chem 2006, 387:583-593.
Oakes S.A., Scorrano L., Opferman J.T., Bassik M.C., Nishino M., Pozzan T., et al. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci U S A 2005, 102:105-110.
Onouchi Y., Gunji T., Burns J.C., Shimizu C., Newburger J.W., Yashiro M., et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008, 40:35-42.
Pattni K., Banting G. Ins(1,4,5)P3 metabolism and the family of IP3-3Kinases. Cell Signal 2004, 16:643-654.
Pinton P., Ferrari D., Magalhães P., Schulze-Osthoff K., Di Virgilio F., Pozzan T., et al. Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J Cell Biol 2000, 148:857-862.
Pouillon V., Hascakova-Bartova R., Pajak B., Adam E., Bex F., Dewaste V., et al. Inositol 1,3,4,5-tetrakisphosphate is essential for T lymphocyte development. Nat Immunol 2003, 4:1136-1143.
Resnick A.C., Saiardi A. Inositol polyphosphate multikinase: metabolic architect of nuclear inositides. Front Biosci 2008, 13:856-866.
Scorrano L., Oakes S.A., Opferman J.T., Cheng E.H., Sorcinelli M.D., Pozzan T., et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 2003, 300:135-139.
Seeds A.M., Bastidas R.J., York J.D. Molecular definition of a novel inositol polyphosphate metabolic pathway initiated by inositol 1,4,5-trisphosphate 3-kinase activity in Saccharomyces cerevisiae. J Biol Chem 2005, 280:27654-27661.
Shears S.B. The versatility of inositol phosphates as cellular signals. Biochim Biophys Acta 1998, 1436:49-67.
Shi Y., Azab A.N., Thompson M.N., Greenberg M.L. Inositol phosphates and phosphoinositides in health and disease. Subcell Biochem 2006, 39:265-292.
Smith P.M. Ins(1,3,4,5)P4 promotes sustained activation of the Ca(2+(-dependent Cl-)) current in isolated mouse lacrimal cells. Biochem J 1992, 283:27-30.
Vanweyenberg V., Communi D., D'Santos C.S., Erneux C. Tissue- and cell-specific expression of Ins(1,4,5)P3 3-kinase isoenzymes. Biochem J 1995, 306:429-435.
Wen B.G., Pletcher M.T., Warashina M., Choe S.H., Ziaee N., Wiltshire T., et al. Inositol (1,4,5) trisphosphate 3 kinase B controls positive selection of T cells and modulates Erk activity. Proc Natl Acad Sci U S A 2004, 101:5604-5609.
Windhorst S., Fliegert R., Blechner C., Möllmann K., Hosseini Z., Günther T., et al. Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell motility-promoting protein that increases the metastatic potential of tumor cells by two functional activities. J Biol Chem 2010, 285:5541-5554.
